DK1347974T3 - Aminotriazolopyridinderivater som adenosinreceptorligander - Google Patents

Aminotriazolopyridinderivater som adenosinreceptorligander

Info

Publication number: DK1347974T3
Authority: DK; Denmark
Prior art keywords: aminotriazolopyridine; derivatives; receptor ligands; adenosine receptor; adenosine
Prior art date: 2000-12-15

Application number

DK01991804T

Other languages

Danish (da)

English (en)

Inventor

Bernd Brodbeck

Matthias Heinrich Nettekoven

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-15

Filing date

2001-12-07

Publication date

2005-03-14

2001-12-07 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2005-03-14 Application granted granted Critical

2005-03-14 Publication of DK1347974T3 publication Critical patent/DK1347974T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK01991804T 2000-12-15 2001-12-07 Aminotriazolopyridinderivater som adenosinreceptorligander DK1347974T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00127567		2000-12-15
EP01991804A EP1347974B1 (fr)	2000-12-15	2001-12-07	Derives d'aminotriazolopyridine en tant que ligands du recepteur d'adenosine
PCT/EP2001/014399 WO2002048145A1 (fr)	2000-12-15	2001-12-07	Derives d'aminotriazolopyridine en tant que ligands du recepteur d'adenosine

Publications (1)

Publication Number	Publication Date
DK1347974T3 true DK1347974T3 (da)	2005-03-14

Family

ID=8170683

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01991804T DK1347974T3 (da)	2000-12-15	2001-12-07	Aminotriazolopyridinderivater som adenosinreceptorligander

Country Status (21)

Country	Link
US (1)	US6506772B1 (fr)
EP (1)	EP1347974B1 (fr)
JP (1)	JP4049672B2 (fr)
KR (1)	KR100540628B1 (fr)
CN (1)	CN1221551C (fr)
AR (1)	AR031799A1 (fr)
AT (1)	ATE281456T1 (fr)
AU (2)	AU3167402A (fr)
BR (1)	BR0116193A (fr)
CA (1)	CA2437006C (fr)
DE (1)	DE60106974T2 (fr)
DK (1)	DK1347974T3 (fr)
ES (1)	ES2230387T3 (fr)
GT (1)	GT200100253A (fr)
MX (1)	MXPA03005334A (fr)
PA (1)	PA8534701A1 (fr)
PE (1)	PE20020666A1 (fr)
PT (1)	PT1347974E (fr)
UY (1)	UY27074A1 (fr)
WO (1)	WO2002048145A1 (fr)
ZA (1)	ZA200304481B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4101755B2 (ja) *	2001-10-08	2008-06-18	エフ．ホフマン−ラロシュアーゲー	８−アミノ−〔１，２，４〕トリアゾロ〔１，５−ａ〕ピリジン−６−カルボン酸アミド
EP1556053A4 (fr) *	2002-10-31	2006-04-19	Amgen Inc	Agents anti-inflammatoires
RU2388751C2 (ru)	2004-07-15	2010-05-10	Амр Текнолоджи, Инк.	Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
WO2008006540A1 (fr) *	2006-07-12	2008-01-17	Syngenta Participations Ag	Dérivés de triazolpyridine utilisés comme herbicides
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
CA2760837C (fr) *	2009-05-12	2018-04-03	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline et son utilisation
WO2010132487A1 (fr) *	2009-05-12	2010-11-18	Bristol-Myers Squibb Company	Formes cristallines de (s)-7-([1,2,4]triazolo[1,5-a] pyridin -6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline et leurs utilisations
KR20120034644A (ko) *	2009-05-12	2012-04-12	알바니 몰레큘라 리써치, 인크.	아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
EP2757883B1 (fr)	2011-09-22	2021-01-13	Merck Sharp & Dohme Corp.	Composés triazolopyridyle à utiliser en tant qu'inhibiteurs de l'aldostérone synthase
WO2013043518A1 (fr)	2011-09-22	2013-03-28	Merck Sharp & Dohme Corp.	Composés imidazopyridyliques utilisables en tant qu'inhibiteurs de l'aldostérone synthase
WO2020054712A1 (fr) *	2018-09-12	2020-03-19	日本化薬株式会社	Agent de lutte contre les organismes nuisibles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
US5356894A (en)	1990-05-29	1994-10-18	Rodney Peter W	Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist
AU2639299A (en)	1998-02-24	1999-09-15	Kyowa Hakko Kogyo Co. Ltd.	Remedies/preventives for parkinson's disease
US6355653B1 (en)	1999-09-06	2002-03-12	Hoffmann-La Roche Inc.	Amino-triazolopyridine derivatives

2001
- 2001-11-30 US US09/998,323 patent/US6506772B1/en not_active Expired - Fee Related
- 2001-12-07 KR KR1020037008004A patent/KR100540628B1/ko not_active Expired - Fee Related
- 2001-12-07 MX MXPA03005334A patent/MXPA03005334A/es active IP Right Grant
- 2001-12-07 EP EP01991804A patent/EP1347974B1/fr not_active Expired - Lifetime
- 2001-12-07 WO PCT/EP2001/014399 patent/WO2002048145A1/fr not_active Ceased
- 2001-12-07 ES ES01991804T patent/ES2230387T3/es not_active Expired - Lifetime
- 2001-12-07 AU AU3167402A patent/AU3167402A/xx active Pending
- 2001-12-07 AU AU2002231674A patent/AU2002231674B2/en not_active Ceased
- 2001-12-07 DE DE60106974T patent/DE60106974T2/de not_active Expired - Lifetime
- 2001-12-07 JP JP2002549676A patent/JP4049672B2/ja not_active Expired - Fee Related
- 2001-12-07 PT PT01991804T patent/PT1347974E/pt unknown
- 2001-12-07 CA CA002437006A patent/CA2437006C/fr not_active Expired - Fee Related
- 2001-12-07 DK DK01991804T patent/DK1347974T3/da active
- 2001-12-07 CN CNB018220304A patent/CN1221551C/zh not_active Expired - Fee Related
- 2001-12-07 AT AT01991804T patent/ATE281456T1/de active
- 2001-12-07 BR BR0116193-8A patent/BR0116193A/pt not_active Application Discontinuation
- 2001-12-12 AR ARP010105765A patent/AR031799A1/es unknown
- 2001-12-12 PA PA20018534701A patent/PA8534701A1/es unknown
- 2001-12-12 PE PE2001001245A patent/PE20020666A1/es not_active Application Discontinuation
- 2001-12-14 UY UY27074A patent/UY27074A1/es not_active Application Discontinuation
- 2001-12-14 GT GT200100253A patent/GT200100253A/es unknown
2003
- 2003-06-09 ZA ZA200304481A patent/ZA200304481B/en unknown

Also Published As

Publication number	Publication date
CA2437006A1 (fr)	2002-06-20
PE20020666A1 (es)	2002-07-27
GT200100253A (es)	2002-07-31
PT1347974E (pt)	2005-02-28
ZA200304481B (en)	2004-09-09
AR031799A1 (es)	2003-10-01
JP2004521096A (ja)	2004-07-15
CA2437006C (fr)	2009-10-27
JP4049672B2 (ja)	2008-02-20
DE60106974D1 (de)	2004-12-09
KR100540628B1 (ko)	2006-01-11
CN1221551C (zh)	2005-10-05
AU3167402A (en)	2002-06-24
EP1347974B1 (fr)	2004-11-03
CN1486314A (zh)	2004-03-31
PA8534701A1 (es)	2002-08-26
MXPA03005334A (es)	2004-04-02
US6506772B1 (en)	2003-01-14
KR20030061446A (ko)	2003-07-18
ES2230387T3 (es)	2005-05-01
DE60106974T2 (de)	2005-11-03
AU2002231674B2 (en)	2006-07-06
ATE281456T1 (de)	2004-11-15
EP1347974A1 (fr)	2003-10-01
WO2002048145A1 (fr)	2002-06-20
BR0116193A (pt)	2003-09-23
UY27074A1 (es)	2002-07-31

Publication	Publication Date	Title
DK1414440T3 (da)	2007-05-21	N-phenylpyrrolguanidinderivater som melanocortinreceptorligander
NO20015477D0 (no)	2001-11-08	4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
NO20013671L (no)	2001-09-26	Substituerte bisycliske derivater nyttige som anticancer midler
NO20032531D0 (no)	2003-06-04	Tetralon-derivater som antitumormidler
DE60119492D1 (de)	2006-06-14	Purinderivate
DE60037345D1 (de)	2008-01-17	Pyrroloi2,3-d pyrimidinderivate enthaltende Zusammensetzungen
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
DK1296996T3 (da)	2004-08-16	Purinderivater
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
PL373953A1 (en)	2005-09-19	7-amino-benzothiazole derivatives as adenosine receptor ligands
ATE306265T1 (de)	2005-10-15	Benzothiazolderivate als adenosin-rezeptor- liganden
DK1322654T3 (da)	2009-04-14	Platinkomplekser som antitumormidler
ATE334114T1 (de)	2006-08-15	Substituierte c-cyclohexylmethylamin-derivate
DK1560828T3 (da)	2006-09-04	Imidazoquinolinderivater som adenosin-A3-receptorligander
NO20043119L (no)	2004-07-20	Triazolokinolinderivater som kan anvendes som adenosinreseptorligander
DK1347974T3 (da)	2005-03-14	Aminotriazolopyridinderivater som adenosinreceptorligander
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
DK1246791T3 (da)	2005-02-14	Aminomethyl-phenyl-cyklohexanonderivater
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
DK1177185T3 (da)	2005-06-06	4,5,6,7-tetrahydroindazolderivater som antitumormidler
DK1345892T3 (da)	2005-06-27	Acylaminoalkylsubstituerede benzensulfonamidderivater